Saturday, September 10, 2016

Merck's Next Federal NuvaRing® MDL Status Hearing Will Occur Next Thursday -- The Agenda Is All Set


Just to keep the readership informed, here -- the vast bulk of these have long ago (as of February 2014) agreed to the total $100 million aggregate class wide settlement figure.

There are some opt-outs, which will eventually likely be remanded back to the local District courts, from whence they came. Here is the Thursday afternoon order, from Missouri's Eastern District:

. . . .JOINT AGENDA FOR SEPTEMBER 15, 2016 STATUS CONFERENCE

Plaintiffs’ counsel Alonso Krangle and counsel for Defendants hereby submit the following matters for discussion during the September 15, 2016 Status Conference:

1. Update on Master Settlement Agreement process and dismissals

2. Update on general discovery

3. Proposal for remand of cases

4. Motion to dismiss Shaffer v. Organon, et al., Case No. 4:16-cv-00724

DATED: September 8, 2016. . . .


Now you know. Onward -- heading to the north woods.

नमस्ते

No comments: